Skip to content

Pediatric brain‑tumor research stalled after NIH funding lapse

scienceNov 16, 202637205

The National Cancer Institute did not renew the Pediatric Brain Tumor Consortium’s $4 million annual grant, and the consortium was terminated, forcing the closure or pause of eight ongoing clinical trials for diffuse intrinsic pontine glioma and related fatal pediatric brain tumors. The consortium had operated for 27 years as a central coordinated network for pediatric brain‑tumor studies. Families such as Amanda and Aaron Schecter, whose 5‑year‑old daughter Ryleigh was diagnosed this year with an incurable brain tumor, lost access to trials clinicians had been using as avenues of hope. Clinicians including Dr. Ira Dunkel say the funding lapse wiped out immediate treatment options and the loss of progress and opportunity for patients and parents. The interruption has stalled research pipelines and delayed testing of potential therapies for tumors that typically kill children within a year, leaving investigators to rehome studies or pause enrollment while federal support is resolved.

1 source